Recent Analysts’ Ratings Changes for HCA Healthcare (HCA)

HCA Healthcare (NYSE: HCA) recently received a number of ratings updates from brokerages and research firms:

• 12/22/2025 – HCA Healthcare had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.
• 12/19/2025 – HCA Healthcare had its price target raised by analysts at Royal Bank Of Canada from $482.00 to $525.00. They now have an “outperform” rating on the stock.
• 12/18/2025 – HCA Healthcare had its price target raised by analysts at Mizuho from $505.00 to $520.00. They now have an “outperform” rating on the stock.
• 12/15/2025 – HCA Healthcare had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.
• 12/15/2025 – HCA Healthcare was downgraded by analysts at Morgan Stanley from an “equal weight” rating to an “underweight” rating. They now have a $425.00 price target on the stock.
• 12/11/2025 – HCA Healthcare had its price target raised by analysts at Robert W. Baird from $423.00 to $450.00. They now have a “neutral” rating on the stock.
• 12/8/2025 – HCA Healthcare had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.
• 12/1/2025 – HCA Healthcare had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.
• 11/27/2025 – HCA Healthcare was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating.
• 11/24/2025 – HCA Healthcare had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.
• 11/17/2025 – HCA Healthcare had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.
• 11/13/2025 – HCA Healthcare had its price target raised by analysts at Wells Fargo & Company from $412.00 to $431.00. They now have an “equal weight” rating on the stock.
• 10/29/2025 – HCA Healthcare was upgraded by analysts at Zacks Research from a “hold” rating to a “strong-buy” rating.
• 10/28/2025 – HCA Healthcare had its price target raised by analysts at Jefferies Financial Group Inc. from $485.00 to $525.00. They now have a “buy” rating on the stock.
• 10/27/2025 – HCA Healthcare had its “buy” rating reaffirmed by analysts at Cowen Inc.
• 10/27/2025 – HCA Healthcare had its price target raised by analysts at Barclays PLC from $445.00 to $494.00. They now have an “overweight” rating on the stock.
• 10/27/2025 – HCA Healthcare had its price target raised by analysts at UBS Group AG from $495.00 to $525.00. They now have a “buy” rating on the stock.
• 10/27/2025 – HCA Healthcare was given a new $425.00 price target on by analysts at Morgan Stanley.
• 10/27/2025 – HCA Healthcare had its price target raised by analysts at The Goldman Sachs Group, Inc. from $470.00 to $520.00. They now have a “buy” rating on the stock.
• 10/27/2025 – HCA Healthcare was given a new $525.00 price target on by analysts at Raymond James Financial, Inc..
• 10/27/2025 – HCA Healthcare had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald.
• 10/27/2025 – HCA Healthcare had its “market perform” rating reaffirmed by analysts at Sanford C. Bernstein. They now have a $417.00 price target on the stock.
• 10/27/2025 – HCA Healthcare had its price target raised by analysts at Bank of America Corporation from $430.00 to $470.00. They now have a “neutral” rating on the stock.
• 10/27/2025 – HCA Healthcare had its price target raised by analysts at TD Cowen from $380.00 to $490.00. They now have a “buy” rating on the stock.
• 10/27/2025 – HCA Healthcare had its price target raised by analysts at Royal Bank Of Canada from $449.00 to $482.00. They now have an “outperform” rating on the stock.
• 10/27/2025 – HCA Healthcare had its price target raised by analysts at Stephens from $450.00 to $500.00. They now have an “overweight” rating on the stock.
• 10/27/2025 – HCA Healthcare had its price target raised by analysts at Truist Financial Corporation from $460.00 to $495.00. They now have a “buy” rating on the stock.
• 10/27/2025 – HCA Healthcare had its price target raised by analysts at Mizuho from $475.00 to $505.00. They now have an “outperform” rating on the stock.
• 10/27/2025 – HCA Healthcare had its price target raised by analysts at Oppenheimer Holdings, Inc. from $400.00 to $500.00. They now have an “outperform” rating on the stock.
• 10/27/2025 – HCA Healthcare had its price target raised by analysts at KeyCorp from $465.00 to $475.00. They now have an “overweight” rating on the stock.
• 10/25/2025 – HCA Healthcare was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is currently 11.13%.

Insider Activity

In other news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.30% of the company’s stock.

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.